Iovance Biotherapeutics IOVA
NASDAQ IOVA
$8.09 +0.01 (+0.12%)
At close: Nov 11, 2026 · 4:00 PM EST

Iovance Biotherapeutics (IOVA) Work In Process (2023 - 2025)

Updated

Iovance Biotherapeutics (IOVA) reported Work In Process of $12.09 million for Q1 2025, up 104.4% from $5.91 million a year earlier and up 37.9% from the prior quarter.

Analysis

Iovance Biotherapeutics (IOVA) Work In Process (2023 - 2025) Analysis & Trends

At the end of FY2024, Iovance Biotherapeutics posted Work In Process of $8.77 million, up 52.5% from FY2023.

  • By year, Work In Process came in at $5.75 million in FY2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,348.13 Bn 1,321.74 Bn 20.46 Bn
2 Johnson & Johnson 675.90 Bn 595.76 Bn 17.30 Bn
3 AbbVie 519.45 Bn 487.50 Bn 13.12 Bn
4 Merck 364.95 Bn 327.95 Bn 13.19 Bn
5 Novartis Ag 311.58 Bn 285.16 Bn -
6 Astrazeneca 289.34 Bn 262.94 Bn 13.26 Bn
7 Amgen 251.64 Bn 203.30 Bn 7.58 Bn
8 Gilead Sciences 212.05 Bn 187.07 Bn 6.73 Bn
9 Pfizer 167.35 Bn 115.00 Bn 12.56 Bn
10 Iovance Biotherapeutics 3.74 Bn 2.45 Bn 73.44 Mn
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2025 12.09 Mn
Dec 31, 2024 8.77 Mn
Mar 31, 2024 5.91 Mn
Dec 31, 2023 5.75 Mn
Sep 30, 2023 4.30 Mn
Jun 30, 2023 8.59 Mn
API Access

Iovance Biotherapeutics Work In Process API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=work-in-process&ticker=IOVA&period=max&api_key=YOUR_API_KEY